Obese Pregnant Women: Optimizing Fetal Ultrasound

November 9, 2015 updated by: Holbaek Sygehus

Obese Pregnant Women: Optimizing Mid-trimester Fetal Ultrasound for Risk Estimation During Pregnancy and Childhood

This study aim to evaluate the quality of fetal ultrasound in obese pregnant women. The hypotheses is that an early ultrasound will improve the quality of the ultrasound in obese.

Study Overview

Status

Unknown

Detailed Description

Ultrasound examination for fetal anomaly is especially challenging in obese gravida. The foetus is more likely to have congenital anomalies and imaging in these patients is technically more difficult.

The investigators hypotheses that an earlier ultrasound with alternative technics will improve the quality and thereby improve the identification of anomalies. By using transvaginal ultrasound and abdominal ultrasound at the window just above the symphysis, were the subcutaneous fat is known to be thinner, the investigators hope to achieve a better overview. This will be done by evaluating fetal ultrasound at three different gestational ages (GA); GA 13, 15 and 21 weeks.

Study Type

Observational

Enrollment (Anticipated)

180

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Holbaek, Denmark, 4300
        • Recruiting
        • Department of Gynaechology and Obstetrics, Holbaek Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • Ida Thagaard, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Sixty pregnant women with BMI ≥ 30 Kg/m2, 60 pregnant women with BMI ≥ 35 Kg/m2 and 60 Kg/m2 pregnant women normal weighted (BMI: 18,5-24,9 Kg/m2) will be included.

Women will be classified by their pre-pregnancy BMI and all pregnant women with an age ≥ 18 will be offered to attend the project and those who accept will be admitted. The recruitment will be performed at Holbæk Hospital and Odense University Hospital.

Description

Inclusion Criteria:

  • Age ≥ 18
  • BMI ≥ 30 Kg/m2
  • BMI: 18,5-25 Kg/m2
  • Understand and speak Danish and thereby be able to give confirmed consent.

Exclusion Criteria:

  • Multiple gestations
  • Overweight (BMI: 25-29,9 Kg/m2)
  • Alcohol or drug abuse
  • Chronically diseases before pregnancy as diabetes, hypertension, or thyroid diseases
  • Gastric bypass or other obesity related surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Moderat Obesity
60 persons with BMI between 30-34.49 kg/m2
Sever Obesity
60 persons with BMI above 34.49 kg/m2
Normal weighted
60 persons with BMI between 18.5-24.49 kg/m2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Image quality of ultrasound at 15 compared with 21 weeks of gestation.
Time Frame: The participants will be examined for an hour at to different stages of the pregnancy (GA 14+0-15+0, GA 20+0-21+0)
Image quality evaluated by experts on a visual analog scale from +50 - -50, parried with standardized ultrasound pictures at the above mentioned GA.
The participants will be examined for an hour at to different stages of the pregnancy (GA 14+0-15+0, GA 20+0-21+0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Image quality of ultrasound at 13 compared with 15 weeks of gestation.
Time Frame: The participants will be examined for an hour at to different stages of the pregnancy (GA 11+3 - 13+0, GA 14+0-15+0)
Image quality evaluated by experts on a visual analog scale from +50 - -50, parried with standardized ultrasound pictures at the above mentioned GA.
The participants will be examined for an hour at to different stages of the pregnancy (GA 11+3 - 13+0, GA 14+0-15+0)
Analyses of BMI, visceral to subcutaneous fat ratio, distance from cutis to amnion and hip-waist ratio´s influence on image quality.
Time Frame: The participants will be examined for an hour at three different stages of the pregnancy (GA 13, GA 15, GA 21 and GA 36 weeks).
The participants will be examined for an hour at three different stages of the pregnancy (GA 13, GA 15, GA 21 and GA 36 weeks).
Weight estimate
Time Frame: The participants will be examined for an hour at GA 36 weeks. The participants will in all be followed until 6 months after birth, which is one year in all.
The use of weight estimate in obese pregnant women at GA 36 compared to birthweight.
The participants will be examined for an hour at GA 36 weeks. The participants will in all be followed until 6 months after birth, which is one year in all.
Amnion fluid in obese
Time Frame: The participants will be examined for an hour at three different stages of the pregnancy (GA 15, GA 21, GA 36 weeks)
Measurement of amnion fluid by deepest vertical pocket and amnion fluid index.
The participants will be examined for an hour at three different stages of the pregnancy (GA 15, GA 21, GA 36 weeks)
Crown-rump length (CRL) measurement transvaginal and abdominal
Time Frame: The participants will be examined for an hour at GA 13 weeks.
Measurement of CRL in mm, by using two different probes, transvaginal and abdominal.
The participants will be examined for an hour at GA 13 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Ida Näslund Thagaard, M.D., Department of obstetrics and gynecology, Holbæk Hospital, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2015

Primary Completion (Anticipated)

January 1, 2017

Study Completion (Anticipated)

March 1, 2017

Study Registration Dates

First Submitted

June 23, 2015

First Submitted That Met QC Criteria

June 30, 2015

First Posted (Estimate)

July 1, 2015

Study Record Updates

Last Update Posted (Estimate)

November 10, 2015

Last Update Submitted That Met QC Criteria

November 9, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 12-000095

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

3
Subscribe